Login to Your Account

Taigen gets nod for first made-in-Taiwan drug in mainland China

By Pearl Liu and Bonnie Wang
Staff Writers

Tuesday, June 21, 2016

HONG KONG – With a green light from the CFDA, Taiwan antibiotics maker Taigen Biotechnology Co. Ltd. now has the first made-in-Taiwan novel drug marketed in mainland China.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription